Harinder S. Juneja

1.9k total citations
54 papers, 1.3k citations indexed

About

Harinder S. Juneja is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Harinder S. Juneja has authored 54 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 19 papers in Genetics and 8 papers in Molecular Biology. Recurrent topics in Harinder S. Juneja's work include Hemoglobinopathies and Related Disorders (10 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Myeloid Leukemia Research (7 papers). Harinder S. Juneja is often cited by papers focused on Hemoglobinopathies and Related Disorders (10 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Acute Myeloid Leukemia Research (7 papers). Harinder S. Juneja collaborates with scholars based in United States and China. Harinder S. Juneja's co-authors include Nena Aleksic, Kenneth K. Wu, Aaron R. Folsom, Veikko Salomaa, Diane Catellier, Eunsik Park, Chul Ahn, Frank H. Gardner, Eric Boerwinkle and Lloyd E. Chambless and has published in prestigious journals such as The Lancet, Circulation and Nature Medicine.

In The Last Decade

Harinder S. Juneja

52 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harinder S. Juneja United States 16 494 348 250 221 217 54 1.3k
Michael Mansfield United Kingdom 24 732 1.5× 487 1.4× 114 0.5× 191 0.9× 463 2.1× 52 2.1k
Suzanne J.A. Korporaal Netherlands 22 288 0.6× 382 1.1× 59 0.2× 341 1.5× 193 0.9× 51 1.5k
Marie‐Hélène Gaugler France 26 272 0.6× 159 0.5× 128 0.5× 537 2.4× 68 0.3× 49 1.8k
Kensaku Nishihira Japan 19 171 0.3× 460 1.3× 72 0.3× 231 1.0× 190 0.9× 94 1.3k
Giovanna Marchetti Italy 24 1.5k 3.1× 255 0.7× 457 1.8× 363 1.6× 43 0.2× 101 2.1k
Claudia G. Sáez Chile 18 289 0.6× 187 0.5× 55 0.2× 418 1.9× 73 0.3× 47 1.1k
Yvonne H. Datta United States 15 121 0.2× 218 0.6× 73 0.3× 216 1.0× 106 0.5× 24 982
Huaien Zheng Canada 15 117 0.2× 120 0.3× 70 0.3× 251 1.1× 94 0.4× 25 1.1k
Boris Aleil France 11 302 0.6× 565 1.6× 37 0.1× 161 0.7× 204 0.9× 22 1.3k
P. Ferraresi Italy 19 546 1.1× 392 1.1× 198 0.8× 84 0.4× 192 0.9× 34 1.3k

Countries citing papers authored by Harinder S. Juneja

Since Specialization
Citations

This map shows the geographic impact of Harinder S. Juneja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harinder S. Juneja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harinder S. Juneja more than expected).

Fields of papers citing papers by Harinder S. Juneja

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harinder S. Juneja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harinder S. Juneja. The network helps show where Harinder S. Juneja may publish in the future.

Co-authorship network of co-authors of Harinder S. Juneja

This figure shows the co-authorship network connecting the top 25 collaborators of Harinder S. Juneja. A scholar is included among the top collaborators of Harinder S. Juneja based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harinder S. Juneja. Harinder S. Juneja is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Juneja, Harinder S., et al.. (2024). Hematologic complications after kidney and pancreas transplant in a patient with chronic myeloid leukemia. Cleveland Clinic Journal of Medicine. 91(3). 183–190. 1 indexed citations
2.
Maiti, Abhishek, et al.. (2022). Refractory Hydroa Vacciniforme-Like Lymphoma: Biological Insights from Morphoproteomic Analysis. International Journal of Hematology-Oncology and Stem Cell Research. 16(3). 177–183.
3.
Lachowiez, Curtis A., Harinder S. Juneja, Wei Qiao, et al.. (2021). Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System. Clinical Lymphoma Myeloma & Leukemia. 21(11). e895–e902. 4 indexed citations
4.
Liu, Hong, Morayo G. Adebiyi, Anren Song, et al.. (2018). Elevated ecto-5′-nucleotidase: a missing pathogenic factor and new therapeutic target for sickle cell disease. Blood Advances. 2(15). 1957–1968. 12 indexed citations
5.
Wu, Hongyu, Mikhail Bogdanov, Yujin Zhang, et al.. (2016). Hypoxia-mediated impaired erythrocyte Lands’ Cycle is pathogenic for sickle cell disease. Scientific Reports. 6(1). 29637–29637. 61 indexed citations
6.
Ikoma, Naruhiko, Maro Ohanian, Harinder S. Juneja, et al.. (2014). Portal Vein Thrombosis After Laparoscopic Cholecystectomy. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 18(1). 125–127. 9 indexed citations
7.
Ohanian, Maro, Richard S.P. Huang, Zeev Estrov, et al.. (2014). Isolated Mesenteric CD20-Positive Myeloid Sarcoma. Clinical Lymphoma Myeloma & Leukemia. 14(6). e217–e220. 10 indexed citations
8.
Quesada, Jorge R., et al.. (2012). Case of polycythemia vera concurrent with FIP1L1-PDGFRA–positive myeloproliferative neoplasm with eosinophilia. Cancer Genetics. 205(10). 519–522. 1 indexed citations
9.
Zhang, Yujin, Yingbo Dai, Jiaming Wen, et al.. (2010). Detrimental effects of adenosine signaling in sickle cell disease. Nature Medicine. 17(1). 79–86. 139 indexed citations
10.
Walker, Julie, et al.. (2009). Dapsone induced methemoglobinemia in a patient with glioblastoma. Journal of Neuro-Oncology. 94(1). 149–152. 10 indexed citations
11.
Aleksic, Nena, et al.. (2008). Assessment of coronary heart disease risk by combined analysis of coagulation factors. Atherosclerosis. 198(2). 294–300. 13 indexed citations
12.
Aleksic, Nena, Chul Ahn, Harinder S. Juneja, et al.. (2002). Factor XIIIA Val34Leu Polymorphism Does Not Predict Risk of Coronary Heart Disease. Arteriosclerosis Thrombosis and Vascular Biology. 22(2). 348–352. 32 indexed citations
13.
Juneja, Harinder S., Sang Hun Lee, Vilmos Thomázy, Gregory L. Shipley, & Peter J. Davies. (2001). Acute Activation of gp130 Gene Expression in Bone Marrow Stromal Cells by Contact with Myeloma-Derived Lymphoblastic Cell Line ARH77 Cell Membranes. Journal of Interferon & Cytokine Research. 21(3). 157–166. 3 indexed citations
14.
Salomaa, Veikko, Nena Aleksic, Leticia Sansores-García, et al.. (2001). Cross-sectional association of soluble thrombomodulin with mild peripheral artery disease; the ARIC study. Atherosclerosis. 157(2). 309–314. 31 indexed citations
15.
Wu, Kenneth K., Nena Aleksic, Chul Ahn, et al.. (2001). Thrombomodulin Ala455Val Polymorphism and Risk of Coronary Heart Disease. Circulation. 103(10). 1386–1389. 61 indexed citations
16.
Aleksic, Nena, Harinder S. Juneja, Aaron R. Folsom, et al.. (2000). Platelet Pl A2 Allele and Incidence of Coronary Heart Disease. Circulation. 102(16). 1901–1905. 31 indexed citations
17.
Juneja, Harinder S., Frank C. Schmalstieg, Sang Hun Lee, & Jian Chen. (1998). CD45 partially mediates heterotypic adhesion between murine leukemia/lymphoma cell line L5178Y and marrow stromal cells. Leukemia Research. 22(9). 805–815. 2 indexed citations
18.
Juneja, Harinder S., et al.. (1995). Successful in vitro purging of leukemic blasts from marrow by cortivazol, a pyrazolosteroid: a preclinical study for autologous transplantation in acute lymphoblastic leukemia and non-Hodgkin's lymphoma.. PubMed. 9(10). 1771–8. 8 indexed citations
19.
Juneja, Harinder S. & Sang‐Hun Lee. (1988). In-vivo and in-vitro association between leukemic cells and marrow stromal cells: A murine model. Leukemia Research. 12(8). 631–636. 2 indexed citations
20.
Gardner, Frank H. & Harinder S. Juneja. (1987). Androstane therapy to treat aplastic anaemia in adults: an uncontrolled pilot study. British Journal of Haematology. 65(3). 295–300. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael Mansfield Breakdown of academic impact, for papers by Suzanne J.A. Korporaal Breakdown of academic impact, for papers by Marie‐Hélène Gaugler Breakdown of academic impact, for papers by Kensaku Nishihira Breakdown of academic impact, for papers by Giovanna Marchetti Breakdown of academic impact, for papers by Claudia G. Sáez Breakdown of academic impact, for papers by Yvonne H. Datta Breakdown of academic impact, for papers by Huaien Zheng Breakdown of academic impact, for papers by Boris Aleil Breakdown of academic impact, for papers by P. Ferraresi
Rankless by CCL
2026